Mary Beth DeLena

Senior Vice President, Deputy GC at Alnylam Pharmaceuticals - Cambridge, Massachusetts, US

Mary Beth DeLena's Colleagues at Alnylam Pharmaceuticals
Julio Morillo

Manager, Special Studies

Contact Julio Morillo

Meaghan Young

Associate Director, Launch Excellence

Contact Meaghan Young

Shannon Pustis

Trial Master File (eTMF) (Consultant)

Contact Shannon Pustis

Sarah McAnaw

Senior Manager, Medical Research

Contact Sarah McAnaw

Ashish Garg

Senior Scientist- Analytical Developement CMC

Contact Ashish Garg

Kiara Donald

Senior Research Associate

Contact Kiara Donald

View All Mary Beth DeLena's Colleagues
Mary Beth DeLena's Contact Details
HQ
(617) 551-8200
Location
Greater Boston
Company
Alnylam Pharmaceuticals
Mary Beth DeLena's Company Details
Alnylam Pharmaceuticals logo, Alnylam Pharmaceuticals contact details

Alnylam Pharmaceuticals

Cambridge, Massachusetts, US • 2460 Employees
SaaS

ALNYLAM IS LEADING THE RNAi REVOLUTION™ Alnylam is a leading independent biopharmaceutical company and the pioneer in RNA interference (RNAi) therapeutics – a revolutionary approach to treating diseases which “silences” the genes that cause or contribute to them. Founded in 2002 by a group of distinguished researchers and biotech leaders, Alnylam’s work over more than two decades has yielded the critical breakthroughs and advancements that have made the field of (RNAi) therapeutics possible. In 2018, our first commercial medicine, and the world’s first RNAi therapeutic was approved. Since then, four more Alnylam-developed medicines have been approved and we’re hard at work developing new therapies to treat both rare and prevalent diseases. We are a global and diverse company of 2,500+ people. We pride ourselves on fostering a fun, inclusive and dynamic work environment where employees can recognize their fullest potential. That's why we’re consistently ranked as a top employer by The Boston Globe (2015-23), Science Magazine (2018-23), Fast Company (Best Workplaces for Innovators 2020-23) and LinkedIn (2024). We are based in Cambridge, Massachusetts (U.S.), with offices throughout North America, Europe, Asia, and South America. See our social media community guidelines: https://bit.ly/2FcRhJy. Please note: If you wish to report an adverse event or product complaint, please email medinfo@alnylam.com or you may call us using the following telephone numbers: for North America, 877.ALNYLAM (877.256.9526), for Europe, +31 20 369 7861

Rna Therapeutics Innovative Treatments Ocular Disease Treatment
Details about Alnylam Pharmaceuticals
Frequently Asked Questions about Mary Beth DeLena
Mary Beth DeLena currently works for Alnylam Pharmaceuticals.
Mary Beth DeLena's role at Alnylam Pharmaceuticals is Senior Vice President, Deputy GC.
Mary Beth DeLena's email address is ***@alnylam.com. To view Mary Beth DeLena's full email address, please signup to ConnectPlex.
Mary Beth DeLena works in the SaaS industry.
Mary Beth DeLena's colleagues at Alnylam Pharmaceuticals are Chia-Hsing Lin, Julio Morillo, Meaghan Young, Shannon Pustis, Sarah McAnaw, Ashish Garg, Kiara Donald and others.
Mary Beth DeLena's phone number is (617) 551-8200
See more information about Mary Beth DeLena